跳至主要内容
临床试验/JPRN-UMIN000032040
JPRN-UMIN000032040已完成未知

The exploratory study on change of the gutmicrobiota in Rabeprazole divided doses:Direction crossover controlled trial in front of an open label - The exploratory study on change of the gutmicrobiota in the Rabeprazole administration

Shiga University of Medical Science0 个研究点目标入组 12 人开始时间: 2018年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 50years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.No consent 2.With the drug including a suppressant acid-secreting for the past one month. 3.With probiotics (medicine for intestinal disorders) or the antimicrobial agent for the past one month. 4.With grapefruits for the past two weeks. 5.With operating treatment for upper gastrointestinal disease including esophagus and stomach. 6.During pregnancy or nursing.

研究者

相似试验